Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Mitochondrial genes delivered in vivo confer protection against renal I/R injury

May 5, 2014

Allena Pharmaceuticals reports phase I data for ALLN-177

May 2, 2014

PAR-1 antagonist F-16357 dose-dependently inhibits bladder contraction

April 28, 2014

New bicyclic derivatives synthesized by Roche

April 25, 2014

Torii Pharmaceutical set to launch Riona in Japan for the treatment of hyperphosphatemia

April 22, 2014

OxThera receives financing to continue key clinical programs

April 17, 2014

Prevention of PGE2-induced bladder overactivity by TRPM8 blocker DFL-23448

April 17, 2014

French team presents novel V2 receptor antagonist peptides

April 10, 2014

EMA validates Keryx Biopharmaceuticals' MAA for Zerenex

April 3, 2014

AM-Pharma reports phase I data for recombinant human alkaline phosphatase

March 31, 2014

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...